Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? Mar 12, 2026 Life Science
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Mar 11, 2026 Life Science
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
Alleviating Doctors’ Paperwork, Amazon Accelerates AI Healthcare Initiatives Mar 5, 2026 Life Science
Decoding the 2026 Market Leaders: 6 Stocks That Have Already Doubled Mar 2, 2026 Energy, Life Science, Technology
Eli Lilly Soars, Regencell Speculates, but Pfizer’s 6.4% Yield Makes It the Real Value Play Mar 1, 2026 Life Science
Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse Feb 26, 2026 Life Science
Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214% Feb 25, 2026 Life Science
